EVOLVA BIOTECH A/S
CVR number: 25532538
Fruebjergvej 3, 2100 København Ø
tel: 70222365
Income statement (kDKK)
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 59 907.65 | ||||
| External services | -18 031.52 | ||||
| Gross profit | 41 876.13 | 49 857.02 | 2 917.43 | 638.88 | - 116.21 |
| Employee benefit expenses | -35 986.41 | -39 390.07 | -2 807.51 | - 838.57 | -0.22 |
| Other operating expenses | -4 475.78 | ||||
| Total depreciation | -5 707.50 | -5 803.75 | |||
| EBIT | 182.22 | 187.42 | 109.92 | - 199.70 | - 116.43 |
| Other financial income | 221.91 | 162.64 | 177.53 | 74.94 | 36.77 |
| Other financial expenses | -1 023.67 | -1 074.60 | -46.06 | -62.25 | - 117.15 |
| Pre-tax profit | - 619.53 | - 724.54 | 241.39 | - 187.01 | - 196.81 |
| Net earnings | - 619.53 | - 724.54 | 241.39 | - 187.01 | - 196.81 |
Assets (kDKK)
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 4 762.44 | ||||
| Machinery and equipment | 12 544.35 | 3 739.32 | |||
| Advance payments and construction in progress | 883.75 | ||||
| Tangible assets total | 18 190.54 | 3 739.32 | |||
| Other receivables | 6.00 | ||||
| Investments total | 6.00 | ||||
| Non-current other receivables | 6 035.48 | ||||
| Long term receivables total | 6 035.48 | ||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 9 999.11 | 7 946.60 | 5 371.82 | 6 364.29 | |
| Prepayments and accrued income | 100.97 | 4.75 | |||
| Current other receivables | 1 536.08 | 3 656.64 | 6.71 | 15.93 | 16.64 |
| Short term receivables total | 1 637.05 | 13 655.75 | 7 953.31 | 5 387.74 | 6 385.68 |
| Cash and bank deposits | 5 700.47 | 3 653.91 | 97.61 | 1 189.92 | 100.17 |
| Cash and cash equivalents | 5 700.47 | 3 653.91 | 97.61 | 1 189.92 | 100.17 |
| Balance sheet total (assets) | 31 563.54 | 21 048.98 | 8 056.91 | 6 577.67 | 6 485.86 |
Equity and liabilities (kDKK)
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| Share capital | 4 311.58 | 4 311.58 | 4 311.58 | 4 311.58 | 4 311.58 |
| Retained earnings | 3 553.51 | 2 933.98 | 2 209.44 | 2 450.82 | 2 263.81 |
| Profit of the financial year | - 619.53 | - 724.54 | 241.39 | - 187.01 | - 196.81 |
| Shareholders equity total | 7 245.56 | 6 521.02 | 6 762.41 | 6 575.39 | 6 378.58 |
| Non-current leasing loans | 5 335.43 | ||||
| Non-current owed to group member | 9 731.96 | ||||
| Non-current liabilities total | 15 067.39 | ||||
| Current loans from credit institutions | 1 942.07 | 838.05 | 1.13 | ||
| Current trade creditors | 1 688.53 | 1 727.67 | 82.65 | 105.00 | |
| Other non-interest bearing current liabilities | 5 619.99 | 11 701.49 | 1 210.73 | 2.28 | 2.27 |
| Accruals and deferred income | 260.75 | ||||
| Current liabilities total | 9 250.59 | 14 527.97 | 1 294.51 | 2.28 | 107.27 |
| Balance sheet total (liabilities) | 31 563.54 | 21 048.98 | 8 056.91 | 6 577.67 | 6 485.86 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.